Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission

被引:18
作者
Chou, W-C [1 ,2 ]
Peng, K-Y [3 ,4 ]
Lei, W-C [2 ]
Ko, B-S [2 ]
Tsay, W. [2 ]
Kuo, C-H [3 ,5 ]
Tien, H-F [2 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 10764, Taiwan
[3] Natl Taiwan Univ, Ctr Genom Med, Metabol Core Lab, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 10764, Taiwan
[5] Natl Taiwan Univ, Coll Med, Dept Pharm, Taipei 10764, Taiwan
关键词
INTERNAL TANDEM DUPLICATION; IDH2; MUTATIONS; BEARING; GLIOMAS;
D O I
10.1038/leu.2011.215
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:527 / 529
页数:3
相关论文
共 15 条
[1]   Sensitive measurement of quantity dynamics of FLT3 internal tandem duplication at early time points provides prognostic information [J].
Chou, W. -C. ;
Hou, H. -A. ;
Liu, C. -Y. ;
Chen, C. -Y. ;
Lin, L. -I. ;
Huang, Y. -N. ;
Chao, Y. -C. ;
Hsu, C. -A. ;
Huang, C. -F. ;
Tien, H. -F. .
ANNALS OF ONCOLOGY, 2011, 22 (03) :696-704
[2]   Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations [J].
Chou, W-C ;
Tang, J-L ;
Wu, S-J ;
Tsay, W. ;
Yao, M. ;
Huang, S-Y ;
Huang, K-C ;
Chen, C-Y ;
Huang, C-F ;
Tien, H-F .
LEUKEMIA, 2007, 21 (05) :998-1004
[3]   The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia [J].
Chou, W-C ;
Lei, W-C ;
Ko, B-S ;
Hou, H-A ;
Chen, C-Y ;
Tang, J-L ;
Yao, M. ;
Tsay, W. ;
Wu, S-J ;
Huang, S-Y ;
Hsu, S-C ;
Chen, Y-C ;
Chang, Y-C ;
Kuo, K-T ;
Lee, F-Y ;
Liu, M-C ;
Liu, C-W ;
Tseng, M-H ;
Huang, C-F ;
Tien, H-F .
LEUKEMIA, 2011, 25 (02) :246-253
[4]   Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation [J].
Chou, Wen-Chien ;
Hou, Hsin-An ;
Chen, Chien-Yuan ;
Tang, Jih-Luh ;
Yao, Ming ;
Tsay, Woei ;
Ko, Bor-Shen ;
Wu, Shang-Ju ;
Huang, Shang-Yi ;
Hsu, Szu-Chun ;
Chen, Yao-Chang ;
Huang, Yen-Ning ;
Chang, Yi-Chang ;
Lee, Fen-Yu ;
Liu, Ming-Chi ;
Liu, Chia-Wen ;
Tseng, Mei-Hsuan ;
Huang, Chi-Fei ;
Tien, Hwei-Fang .
BLOOD, 2010, 115 (14) :2749-2754
[5]   Cancer-associated IDH1 mutations produce 2-hydroxyglutarate [J].
Dang, Lenny ;
White, David W. ;
Gross, Stefan ;
Bennett, Bryson D. ;
Bittinger, Mark A. ;
Driggers, Edward M. ;
Fantin, Valeria R. ;
Jang, Hyun Gyung ;
Jin, Shengfang ;
Keenan, Marie C. ;
Marks, Kevin M. ;
Prins, Robert M. ;
Ward, Patrick S. ;
Yen, Katharine E. ;
Liau, Linda M. ;
Rabinowitz, Joshua D. ;
Cantley, Lewis C. ;
Thompson, Craig B. ;
Heiden, Matthew G. Vander ;
Su, Shinsan M. .
NATURE, 2009, 462 (7274) :739-U52
[6]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567
[7]   IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria [J].
Kranendijk, Martijn ;
Struys, Eduard A. ;
van Schaftingen, Emile ;
Gibson, K. Michael ;
Kanhai, Warsha A. ;
van der Knaap, Marjo S. ;
Amiel, Jeanne ;
Buist, Neil R. ;
Das, Anibh M. ;
de Klerk, Johannis B. ;
Feigenbaum, Annette S. ;
Grange, Dorothy K. ;
Hofstede, Floris C. ;
Holme, Elisabeth ;
Kirk, Edwin P. ;
Korman, Stanley H. ;
Morava, Eva ;
Morris, Andrew ;
Smeitink, Jan ;
Sukhai, Ram N. ;
Vallance, Hilary ;
Jakobs, Cornelis ;
Salomons, Gajja S. .
SCIENCE, 2010, 330 (6002) :336-336
[8]   IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study [J].
Marcucci, Guido ;
Maharry, Kati ;
Wu, Yue-Zhong ;
Radmacher, Michael D. ;
Mrozek, Krzysztof ;
Margeson, Dean ;
Holland, Kelsi B. ;
Whitman, Susan P. ;
Becker, Heiko ;
Schwind, Sebastian ;
Metzeler, Klaus H. ;
Powell, Bayard L. ;
Carter, Thomas H. ;
Kolitz, Jonathan E. ;
Wetzler, Meir ;
Carroll, Andrew J. ;
Baer, Maria R. ;
Caligiuri, Michael A. ;
Larson, Richard A. ;
Bloomfield, Clara D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) :2348-2355
[9]   IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication [J].
Paschka, Peter ;
Schlenk, Richard F. ;
Gaidzik, Verena I. ;
Habdank, Marianne ;
Kroenke, Jan ;
Bullinger, Lars ;
Spaeth, Daniela ;
Kayser, Sabine ;
Zucknick, Manuela ;
Goetze, Katharina ;
Horst, Heinz-A. ;
Germing, Ulrich ;
Doehner, Hartmut ;
Doehner, Konstanze .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3636-3643
[10]   Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas [J].
Sanson, Marc ;
Marie, Yannick ;
Paris, Sophie ;
Idbaih, Ahmed ;
Laffaire, Julien ;
Ducray, Francois ;
El Hallani, Soufiane ;
Boisselier, Blandine ;
Mokhtari, Karima ;
Hoang-Xuan, Khe ;
Delattre, Jean-Yves .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) :4150-4154